...
机译:AIDI注射液的临床疗效和安全性加入多西紫杉醇的化疗晚期NONSMALL细胞肺癌:36种随机对照试验的META分析
Zunyi Med Coll Affiliated Hosp Evidence Based Med Ctr MOE Virtual Res Ctr Evidence Based Med;
Zunyi Med Coll Affiliated Hosp Evidence Based Med Ctr MOE Virtual Res Ctr Evidence Based Med;
Hlth Educ Soc Zunyi Project Team Hlth Management &
Decis Making Zunyi 563002 Guizhou Peoples R;
Hlth Educ Soc Zunyi Project Team Hlth Management &
Decis Making Zunyi 563002 Guizhou Peoples R;
Zunyi Med Coll Affiliated Hosp Ctr Evidence Based &
Translat Med Major Infect Di Dept Resp Med;
First Peoples Hosp Zunyi City Dept Neurol Zunyi 563002 Guizhou Peoples R China;
Zunyi Med Coll Affiliated Hosp Evidence Based Med Ctr MOE Virtual Res Ctr Evidence Based Med;
Zunyi Med Coll Sch Pharm Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Coll Sch Pharm Zunyi 563003 Guizhou Peoples R China;
Zunyi Med Coll Affiliated Hosp Dept Oncol Zunyi 563000 Guizhou Peoples R China;
Zunyi Med Coll Special Key Lab Special Antitumor Drugs Guizhou P Zunyi 563003 Guizhou Peoples R;
机译:AIDI注射液的临床疗效和安全性加入多西紫杉醇的化疗晚期NONSMALL细胞肺癌:36种随机对照试验的META分析
机译:AIDI注射液的临床疗效和安全性加入西西紫杉醇的高级源性细胞肺癌:36种随机对照试验的荟萃分析
机译:艾迪注射加紫杉醇的临床疗效和安全性,对紫杉醇的高小细胞肺癌进行:31例随机对照试验后的普遍指南的荟萃分析
机译:细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
机译:表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物:随机对照试验的系统评价。
机译:艾迪注射液加基于多西他赛的化疗在晚期非小细胞肺癌中的临床疗效和安全性:一项36项随机对照试验的荟萃分析
机译:AIDI注射作为晚期乳腺癌辅助治疗的疗效和安全性:随机对照试验的系统评价和荟萃分析